Global RNA Interference (RNAi) Drug Delivery Market Professional Survey Report 2017

August 2017 | 113 pages | ID: G8A7BFEAF46EN
QYResearch

Abstracts

This report studies RNA Interference (RNAi) Drug Delivery in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Metabolic disorders
• Alnylam Pharmaceuticals Inc
• Merck & Co. Inc
• Access Pharmaceuticals Inc
• Dicerna Pharmaceuticals Inc
• Calondo Pharmaceuticals Inc
• Marina Biotech Inc
• RXi Pharmaceuticals Corp
• Quark Pharmaceuticals Inc
• Silence Therapeutics plc
• Tacere Therapeutics Inc
• PhaseRx Inc
• Sirnaomics Inc
• Traversa Therapeutics Inc

By types, the market can be split into

• Nanoparticle Drug Delivery Technology
• Pulmonary Drug Delivery Technology
• Nucleic Acid Drug Delivery Technology
• Aptamer Drug Delivery Technology

By Application, the market can be split into

• Infectious Diseases
• Cardiology
• Oncology
• Neurology
• Ophthalmology
• Metabolic Disorders

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global RNA Interference (RNAi) Drug Delivery Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RNA INTERFERENCE (RNAI) DRUG DELIVERY

1.1 Definition and Specifications of RNA Interference (RNAi) Drug Delivery
  1.1.1 Definition of RNA Interference (RNAi) Drug Delivery
  1.1.2 Specifications of RNA Interference (RNAi) Drug Delivery
1.2 Classification of RNA Interference (RNAi) Drug Delivery
  1.2.1 Nanoparticle Drug Delivery Technology
  1.2.2 Pulmonary Drug Delivery Technology
  1.2.3 Nucleic Acid Drug Delivery Technology
  1.2.4 Aptamer Drug Delivery Technology
1.3 Applications of RNA Interference (RNAi) Drug Delivery
  1.3.1 Infectious Diseases
  1.3.2 Cardiology
  1.3.3 Oncology
  1.3.4 Neurology
  1.3.5 Ophthalmology
  1.3.6 Metabolic Disorders
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RNA INTERFERENCE (RNAI) DRUG DELIVERY

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of RNA Interference (RNAi) Drug Delivery
2.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
2.4 Industry Chain Structure of RNA Interference (RNAi) Drug Delivery

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RNA INTERFERENCE (RNAI) DRUG DELIVERY

3.1 Capacity and Commercial Production Date of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016

4 GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global RNA Interference (RNAi) Drug Delivery Capacity and Growth Rate Analysis
  4.2.2 2016 RNA Interference (RNAi) Drug Delivery Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global RNA Interference (RNAi) Drug Delivery Sales and Growth Rate Analysis
  4.3.2 2016 RNA Interference (RNAi) Drug Delivery Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global RNA Interference (RNAi) Drug Delivery Sales Price
  4.4.2 2016 RNA Interference (RNAi) Drug Delivery Sales Price Analysis (Company Segment)

5 RNA INTERFERENCE (RNAI) DRUG DELIVERY REGIONAL MARKET ANALYSIS

5.1 North America RNA Interference (RNAi) Drug Delivery Market Analysis
  5.1.1 North America RNA Interference (RNAi) Drug Delivery Market Overview
  5.1.2 North America 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.1.4 North America 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis
5.2 China RNA Interference (RNAi) Drug Delivery Market Analysis
  5.2.1 China RNA Interference (RNAi) Drug Delivery Market Overview
  5.2.2 China 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.2.4 China 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis
5.3 Europe RNA Interference (RNAi) Drug Delivery Market Analysis
  5.3.1 Europe RNA Interference (RNAi) Drug Delivery Market Overview
  5.3.2 Europe 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.3.4 Europe 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis
5.4 Southeast Asia RNA Interference (RNAi) Drug Delivery Market Analysis
  5.4.1 Southeast Asia RNA Interference (RNAi) Drug Delivery Market Overview
  5.4.2 Southeast Asia 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.4.4 Southeast Asia 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis
5.5 Japan RNA Interference (RNAi) Drug Delivery Market Analysis
  5.5.1 Japan RNA Interference (RNAi) Drug Delivery Market Overview
  5.5.2 Japan 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.5.4 Japan 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis
5.6 India RNA Interference (RNAi) Drug Delivery Market Analysis
  5.6.1 India RNA Interference (RNAi) Drug Delivery Market Overview
  5.6.2 India 2012-2017E RNA Interference (RNAi) Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price Analysis
  5.6.4 India 2016 RNA Interference (RNAi) Drug Delivery Market Share Analysis

6 GLOBAL 2012-2017E RNA INTERFERENCE (RNAI) DRUG DELIVERY SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E RNA Interference (RNAi) Drug Delivery Sales by Type
6.2 Different Types of RNA Interference (RNAi) Drug Delivery Product Interview Price Analysis
6.3 Different Types of RNA Interference (RNAi) Drug Delivery Product Driving Factors Analysis
  6.3.1 Nanoparticle Drug Delivery Technology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  6.3.2 Pulmonary Drug Delivery Technology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  6.3.3 Nucleic Acid Drug Delivery Technology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  6.3.4 Aptamer Drug Delivery Technology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RNA INTERFERENCE (RNAI) DRUG DELIVERY SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E RNA Interference (RNAi) Drug Delivery Consumption by Application
7.2 Different Application of RNA Interference (RNAi) Drug Delivery Product Interview Price Analysis
7.3 Different Application of RNA Interference (RNAi) Drug Delivery Product Driving Factors Analysis
  7.3.1 Infectious Diseases of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  7.3.2 Cardiology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  7.3.3 Oncology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  7.3.4 Neurology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  7.3.5 Ophthalmology of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis
  7.3.6 Metabolic Disorders of RNA Interference (RNAi) Drug Delivery Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RNA INTERFERENCE (RNAI) DRUG DELIVERY

8.1 Metabolic disorders
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Metabolic disorders 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Metabolic disorders 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.2 Alnylam Pharmaceuticals Inc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Alnylam Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Alnylam Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.3 Merck & Co. Inc
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Merck & Co. Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Merck & Co. Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.4 Access Pharmaceuticals Inc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Access Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Access Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.5 Dicerna Pharmaceuticals Inc
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Dicerna Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Dicerna Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.6 Calondo Pharmaceuticals Inc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Calondo Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Calondo Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.7 Marina Biotech Inc
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Marina Biotech Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Marina Biotech Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.8 RXi Pharmaceuticals Corp
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 RXi Pharmaceuticals Corp 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 RXi Pharmaceuticals Corp 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.9 Quark Pharmaceuticals Inc
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Quark Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Quark Pharmaceuticals Inc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.10 Silence Therapeutics plc
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Silence Therapeutics plc 2016 RNA Interference (RNAi) Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Silence Therapeutics plc 2016 RNA Interference (RNAi) Drug Delivery Business Region Distribution Analysis
8.11 Tacere Therapeutics Inc
8.12 PhaseRx Inc
8.13 Sirnaomics Inc
8.14 Traversa Therapeutics Inc

9 DEVELOPMENT TREND OF ANALYSIS OF RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET

9.1 Global RNA Interference (RNAi) Drug Delivery Market Trend Analysis
  9.1.1 Global 2017-2022 RNA Interference (RNAi) Drug Delivery Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 RNA Interference (RNAi) Drug Delivery Sales Price Forecast
9.2 RNA Interference (RNAi) Drug Delivery Regional Market Trend
  9.2.1 North America 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
  9.2.2 China 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
  9.2.3 Europe 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
  9.2.5 Japan 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
  9.2.6 India 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Forecast
9.3 RNA Interference (RNAi) Drug Delivery Market Trend (Product Type)
9.4 RNA Interference (RNAi) Drug Delivery Market Trend (Application)

10 RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKETING TYPE ANALYSIS

10.1 RNA Interference (RNAi) Drug Delivery Regional Marketing Type Analysis
10.2 RNA Interference (RNAi) Drug Delivery International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of RNA Interference (RNAi) Drug Delivery by Region
10.4 RNA Interference (RNAi) Drug Delivery Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RNA INTERFERENCE (RNAI) DRUG DELIVERY

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of RNA Interference (RNAi) Drug Delivery
Table Product Specifications of RNA Interference (RNAi) Drug Delivery
Table Classification of RNA Interference (RNAi) Drug Delivery
Figure Global Production Market Share of RNA Interference (RNAi) Drug Delivery by Type in 2016
Figure Nanoparticle Drug Delivery Technology Picture
Table Major Manufacturers of Nanoparticle Drug Delivery Technology
Figure Pulmonary Drug Delivery Technology Picture
Table Major Manufacturers of Pulmonary Drug Delivery Technology
Figure Nucleic Acid Drug Delivery Technology Picture
Table Major Manufacturers of Nucleic Acid Drug Delivery Technology
Figure Aptamer Drug Delivery Technology Picture
Table Major Manufacturers of Aptamer Drug Delivery Technology
Table Applications of RNA Interference (RNAi) Drug Delivery
Figure Global Consumption Volume Market Share of RNA Interference (RNAi) Drug Delivery by Application in 2016
Figure Infectious Diseases Examples
Table Major Consumers in Infectious Diseases
Figure Cardiology Examples
Table Major Consumers in Cardiology
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Neurology Examples
Table Major Consumers in Neurology
Figure Ophthalmology Examples
Table Major Consumers in Ophthalmology
Figure Metabolic Disorders Examples
Table Major Consumers in Metabolic Disorders
Figure Market Share of RNA Interference (RNAi) Drug Delivery by Regions
Figure North America RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Figure China RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Figure Europe RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Figure Japan RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Figure India RNA Interference (RNAi) Drug Delivery Market Size (Million USD) (2012-2022)
Table RNA Interference (RNAi) Drug Delivery Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of RNA Interference (RNAi) Drug Delivery in 2016
Figure Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
Figure Industry Chain Structure of RNA Interference (RNAi) Drug Delivery
Table Capacity and Commercial Production Date of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
Table R&D Status and Technology Source of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of RNA Interference (RNAi) Drug Delivery 2012-2017
Figure Global 2012-2017E RNA Interference (RNAi) Drug Delivery Market Size (Volume) and Growth Rate
Figure Global 2012-2017E RNA Interference (RNAi) Drug Delivery Market Size (Value) and Growth Rate
Table 2012-2017E Global RNA Interference (RNAi) Drug Delivery Capacity and Growth Rate
Table 2016 Global RNA Interference (RNAi) Drug Delivery Capacity (K Units) List (Company Segment)
Table 2012-2017E Global RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate
Table 2016 Global RNA Interference (RNAi) Drug Delivery Sales (K Units) List (Company Segment)
Table 2012-2017E Global RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Table 2016 Global RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure North America 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure North America 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure China 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure China 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure Europe 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure Europe 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure Southeast Asia 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure Southeast Asia 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure Japan 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure Japan 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of RNA Interference (RNAi) Drug Delivery 2012-2017E
Figure India 2012-2017E RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit)
Figure India 2016 RNA Interference (RNAi) Drug Delivery Sales Market Share
Table Global 2012-2017E RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type
Table Different Types RNA Interference (RNAi) Drug Delivery Product Interview Price
Table Global 2012-2017E RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application
Table Different Application RNA Interference (RNAi) Drug Delivery Product Interview Price
Table Metabolic disorders Information List
Table Product A Overview
Table Product B Overview
Table 2016 Metabolic disorders RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Metabolic disorders RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Alnylam Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Merck & Co. Inc Information List
Table Product A Overview
Table Product B Overview
Table 2015 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Access Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Dicerna Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Calondo Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Marina Biotech Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table RXi Pharmaceuticals Corp Information List
Table Product A Overview
Table Product B Overview
Table 2016 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Quark Pharmaceuticals Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Silence Therapeutics plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Business Region Distribution
Table Tacere Therapeutics Inc Information List
Table PhaseRx Inc Information List
Table Sirnaomics Inc Information List
Table Traversa Therapeutics Inc Information List
Figure Global 2017-2022 RNA Interference (RNAi) Drug Delivery Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 RNA Interference (RNAi) Drug Delivery Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 RNA Interference (RNAi) Drug Delivery Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 RNA Interference (RNAi) Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of RNA Interference (RNAi) Drug Delivery by Type 2017-2022
Table Global Consumption Volume (K Units) of RNA Interference (RNAi) Drug Delivery by Application 2017-2022
Table Traders or Distributors with Contact Information of RNA Interference (RNAi) Drug Delivery by Region